A cell free protein fragment complementation assay for monitoring the core interaction of the human cytomegalovirus nuclear egress complex

Antiviral Research

Volumn 95, Issue 1, 2012, Pages 12-18

  Schnee, Margit ^a,b   Wagner, Felicia M ^a   Koszinowski, Ulrich H ^a   Ruzsics, Zsolt ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b CureVac GmbH   (Germany)

Author keywords

Antiviral agents; Herpesviruses; Primary envelopment; Protein protein interaction; Viral morphogenesis

Indexed keywords

BETA LACTAMASE; PUL50 PROTEIN; PUL53 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL FREE SYSTEM; CYTOMEGALOVIRUS; NONHUMAN; NUCLEAR EGRESS COMPLEX; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FRAGMENT COMPLEMENTATION ASSAY; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; VALIDATION PROCESS;

ANTIVIRAL AGENTS; BACTERIA; BETA-LACTAMASES; CYTOMEGALOVIRUS; DRUG EVALUATION, PRECLINICAL; HUMANS; PROTEIN BINDING; VIRAL PROTEINS; VIROLOGY; VIRUS RELEASE;

HUMAN HERPESVIRUS 5;

EID: 84862259272     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.04.009     Document Type: Article

References (36)

1. Bjerke S.L., Roller R.J. Roles for herpes simplex virus type 1 UL34 and US3 proteins in disrupting the nuclear lamina during herpes simplex virus type 1 egress. Virology 2006, 347:261-276.
2. Bubeck A., Wagner M., Ruzsics Z., Lotzerich M., Iglesias M., Singh I.R., Koszinowski U.H. Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J. Virol. 2004, 78:8026-8035.
3. Davison A.J. Herpesvirus systematics. Vet. Microbiol. 2010, 143:52-69.
4. De Clercq E., Holy A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat. Rev. Drug Discov. 2005, 4:928-940.
5. De S., Krishnadev O., Srinivasan N., Rekha N. Interaction preferences across protein-protein interfaces of obligatory and non-obligatory components are different. BMC Struct. Biol. 2005, 5:15.
6. Fossum E., Friedel C.C., Rajagopala S.V., Titz B., Baiker A., Schmidt T., Kraus T., Stellberger T., Rutenberg C., Suthram S., Bandyopadhyay S., Rose D., von Brunn A., Uhlmann M., Zeretzke C., Dong Y.A., Boulet H., Koegl M., Bailer S.M., Koszinowski U., Ideker T., Uetz P., Zimmer R., Haas J. Evolutionarily conserved herpesviral protein interaction networks. PLoS Pathog. 2009, 5:e1000570.
7. Galarneau A., Primeau M., Trudeau L.E., Michnick S.W. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions. Nat. Biotechnol. 2002, 20:619-622.
8. Goldner T., Hewlett G., Ettischer N., Ruebsamen-Schaeff H., Zimmermann H., Lischka P. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J. Virol. 2011, 85:10884-10893.
9. Gonnella R., Farina A., Santarelli R., Raffa S., Feederle R., Bei R., Granato M., Modesti A., Frati L., Delecluse H.J., Torrisi M.R., Angeloni A., Faggioni A. Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. J. Virol. 2005, 79:3713-3727.
10. Hashimoto J., Watanabe T., Seki T., Karasawa S., Izumikawa M., Iemura S., Natsume T., Nomura N., Goshima N., Miyawaki A., Takagi M., Shin-Ya K. Novel in vitro protein fragment complementation assay applicable to high-throughput screening in a 1536-well format. J. Biomol. Screen. 2009, 14:970-979.
11. Hwang J.S., Kregler O., Schilf R., Bannert N., Drach J.C., Townsend L.B., Bogner E. Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus. J. Virol. 2007, 81:11604-11611.
12. Johnson D.C., Baines J.D. Herpesviruses remodel host membranes for virus egress. Nat. Rev. Microbiol. 2011, 9:382-394.
13. Klupp B.G., Granzow H., Fuchs W., Keil G.M., Finke S., Mettenleiter T.C. Vesicle formation from the nuclear membrane is induced by coexpression of two conserved herpesvirus proteins. Proc. Natl. Acad. Sci. USA 2007, 104:7241-7246.
14. Klupp B.G., Granzow H., Keil G.M., Mettenleiter T.C. The capsid-associated UL25 protein of the alphaherpesvirus pseudorabies virus is nonessential for cleavage and encapsidation of genomic DNA but is required for nuclear egress of capsids. J. Virol. 2006, 80:6235-6246.
15. Krosky P.M., Baek M.C., Coen D.M. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 2003, 77:905-914.
16. Loregian A., Coen D.M. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem. Biol. 2006, 13:191-200.
17. Loregian A., Palu G. Disruption of protein-protein interactions: towards new targets for chemotherapy. J. Cell. Physiol. 2005, 204:750-762.
18. Loregian A., Rigatti R., Murphy M., Schievano E., Palu G., Marsden H.S. Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit. J. Virol. 2003, 77:8336-8344.
19. Lotzerich M., Ruzsics Z., Koszinowski U.H. Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J. Virol. 2006, 80:73-84.
20. Luker K.E., Smith M.C., Luker G.D., Gammon S.T., Piwnica-Worms H., Piwnica-Worms D. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl. Acad. Sci. USA 2004, 101:12288-12293.
21. Mettenleiter T.C. Budding events in herpesvirus morphogenesis. Virus. Res. 2004, 106:167-180.
22. Michnick S.W., Ear P.H., Manderson E.N., Remy I., Stefan E. Universal strategies in research and drug discovery based on protein-fragment complementation assays. Nat. Rev. Drug Discov. 2007, 6:569-582.
23. Milbradt J., Auerochs S., Marschall M. Cytomegaloviral proteins pUL50 and pUL53 are associated with the nuclear lamina and interact with cellular protein kinase C. J. Gen. Virol. 2007, 88:2642-2650.
24. Milbradt J., Auerochs S., Sticht H., Marschall M. Cytomegaloviral proteins that associate with the nuclear lamina: components of a postulated nuclear egress complex. J. Gen. Virol. 2009, 90:579-590.
25. Mocarski E.S. Comparative analysis of herpesvirus-common proteins. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 2007, Cambridge University Press, Cambridge. A. Arvin, G. Campadelli-Fiume, E.S. Mocarski, P.S. Moore, B. Roizman, R. Whitley, K. Yamanishi (Eds.).
26. Muranyi W., Haas J., Wagner M., Krohne G., Koszinowski U.H. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 2002, 297:854-857.
27. Nixon D.E., McVoy M.A. Dramatic effects of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside on the genome structure, packaging, and egress of guinea pig cytomegalovirus. J. Virol. 2004, 78:1623-1635.
28. Popa M., Ruzsics Z., Lotzerich M., Dolken L., Buser C., Walther P., Koszinowski U.H. Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J. Virol. 2010, 84:9035-9046.
29. Remy I., Michnick S.W. Mapping biochemical networks with protein-fragment complementation assays. Meth. Mol. Biol. 2004, 261:411-426.
30. Reynolds A.E., Liang L., Baines J.D. Conformational changes in the nuclear lamina induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34. J. Virol. 2004, 78:5564-5575.
31. Roller R.J., Bjerke S.L., Haugo A.C., Hanson S. Analysis of a charge-cluster mutation of herpes simplex virus type 1 UL34 and its extragenic suppressor suggest a novel interaction between pUL34 and pUL31 that is necessary for membrane curvature around capsids. J. Virol. 2010, 84:3921-3934.
32. Sam M.D., Evans B.T., Coen D.M., Hogle J.M. Biochemical, biophysical, and mutational analyses of subunit interactions of the human cytomegalovirus nuclear egress complex. J. Virol. 2009, 83:2996-3006.
33. Schnee M., Ruzsics Z., Bubeck A., Koszinowski U.H. Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J. Virol. 2006, 80:11658-11666.
34. Simpson-Holley M., Baines J., Roller R., Knipe D.M. Herpes simplex virus 1 U(L)31 and U(L)34 gene products promote the late maturation of viral replication compartments to the nuclear periphery. J. Virol. 2004, 78:5591-5600.
35. Simpson-Holley M., Colgrove R.C., Nalepa G., Harper J.W., Knipe D.M. Identification and functional evaluation of cellular and viral factors involved in the alteration of nuclear architecture during herpes simplex virus 1 infection. J. Virol. 2005, 79:12840-12851.
36. Yang K., Baines J.D. Selection of HSV capsids for envelopment involves interaction between capsid surface components pUL31, pUL17, and pUL25. Proc. Natl. Acad. Sci. USA 2011, 108:14276-14281.